BioGene Pharmaceutical

BioGene is a specialized pharmaceutical company headquartered in Dubai, UAE, focused on the development and commercialization of innovative therapies in oncology, hematology, and rare diseases. The company operates primarily across the Middle East and North Africa (MENA) region, leveraging strategic partnerships to bring advanced treatments to underserved markets. BioGene's portfolio includes high-value licensed assets, notably through a significant collaboration with BeiGene to commercialize Brukinsa (zanubrutinib) and Tislelizumab in specific territories. By bridging the gap between global biotech innovation and regional patient access, BioGene has established itself as a key player in the MENA healthcare ecosystem.